Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Net Margin (2016 - 2025)

Historic Net Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 12.85%.

  • Bio-Techne's Net Margin rose 11000.0% to 12.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.46%, marking a year-over-year decrease of 74000.0%. This contributed to the annual value of 1.82% for FY2025, which is 92100.0% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Net Margin is 12.85%, which was up 11000.0% from 13.33% recorded in Q3 2025.
  • Bio-Techne's Net Margin's 5-year high stood at 4486.7% during Q3 2022, with a 5-year trough of 21.72% in Q2 2025.
  • Its 5-year average for Net Margin is 236.65%, with a median of 15.66% in 2023.
  • Per our database at Business Quant, Bio-Techne's Net Margin soared by 44599300bps in 2022 and then plummeted by -44682900bps in 2023.
  • Over the past 5 years, Bio-Techne's Net Margin (Quarter) stood at 26.76% in 2021, then crashed by -31bps to 18.41% in 2022, then crashed by -45bps to 10.08% in 2023, then rose by 17bps to 11.75% in 2024, then rose by 9bps to 12.85% in 2025.
  • Its last three reported values are 12.85% in Q4 2025, 13.33% for Q3 2025, and 21.72% during Q2 2025.